Alcohol-Specific Mortality in People With Epilepsy: Cohort Studies in Two Independent Population-Based Datasets

Objectives: The risk of dying by alcohol-specific causes in people with epilepsy has seldom been reported from population-based studies. We aimed to estimate the relative risk of alcohol-specific mortality in people with epilepsy, and the extent to which problematic alcohol use was previously identi...

Full description

Bibliographic Details
Main Authors: Hayley C. Gorton, Roger T. Webb, Rosa Parisi, Matthew J. Carr, Marcos DelPozo-Banos, Kieran J. Moriarty, W. Owen Pickrell, Ann John, Darren M. Ashcroft
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2020.623139/full
_version_ 1818418026894065664
author Hayley C. Gorton
Roger T. Webb
Roger T. Webb
Rosa Parisi
Matthew J. Carr
Matthew J. Carr
Marcos DelPozo-Banos
Kieran J. Moriarty
W. Owen Pickrell
W. Owen Pickrell
Ann John
Darren M. Ashcroft
Darren M. Ashcroft
author_facet Hayley C. Gorton
Roger T. Webb
Roger T. Webb
Rosa Parisi
Matthew J. Carr
Matthew J. Carr
Marcos DelPozo-Banos
Kieran J. Moriarty
W. Owen Pickrell
W. Owen Pickrell
Ann John
Darren M. Ashcroft
Darren M. Ashcroft
author_sort Hayley C. Gorton
collection DOAJ
description Objectives: The risk of dying by alcohol-specific causes in people with epilepsy has seldom been reported from population-based studies. We aimed to estimate the relative risk of alcohol-specific mortality in people with epilepsy, and the extent to which problematic alcohol use was previously identified in the patients' medical records.Method: We delineated cohort studies in two population-based datasets, the Clinical Practice Research Datalink (CPRD GOLD) in England (January 01, 2001–December 31, 2014) and the Secure Anonymised Information Linkage (SAIL) Databank in Wales (January 01, 2001–December 31, 2014), linked to hospitalization and mortality records. People with epilepsy were matched to up to 20 persons without epilepsy on gender, age (±2 years) and registered general practice. We identified alcohol-specific death from Office for National Statistics (ONS) records using specified ICD-10 codes. We further identified prescriptions, interventions and hospitalisations related to alcohol use.Results: In the CPRD GOLD, we identified 9,871 individuals in the incident epilepsy cohort and 185,800 in the comparison cohort and, in the SAIL Databank, these numbers were 5,569 and 110,021, respectively. We identified a five-fold increased risk of alcohol-specific mortality in people with epilepsy vs. those without the condition in our pooled estimate across the two datasets (deprivation-adjusted HR 4.85, 95%CI 3.46–6.79).Conclusions: People with epilepsy are at increased risk of dying by an alcohol-specific cause than those without the disorder. It is plausible that serious alcohol misuse could either contribute to the development of epilepsy or it could commence subsequent to epilepsy being diagnosed. Regardless of the direction of the association, it is important that the risk of dying as a consequence of alcohol misuse is accurately quantified in people affected by epilepsy. Systematically-applied, sensitive assessment of alcohol consumption by healthcare professionals, at opportunistic, clinical contacts, with rapid access to quality treatment services, should be mandatory and play a key role in reduction of health harms and mortality.
first_indexed 2024-12-14T12:16:08Z
format Article
id doaj.art-71eba17568484b2e867e52c9d03e19ea
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-14T12:16:08Z
publishDate 2021-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-71eba17568484b2e867e52c9d03e19ea2022-12-21T23:01:38ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-01-011110.3389/fneur.2020.623139623139Alcohol-Specific Mortality in People With Epilepsy: Cohort Studies in Two Independent Population-Based DatasetsHayley C. Gorton0Roger T. Webb1Roger T. Webb2Rosa Parisi3Matthew J. Carr4Matthew J. Carr5Marcos DelPozo-Banos6Kieran J. Moriarty7W. Owen Pickrell8W. Owen Pickrell9Ann John10Darren M. Ashcroft11Darren M. Ashcroft12School of Applied Sciences, University of Huddersfield, Huddersfield, United KingdomNIHR Greater Manchester Patient Safety Translational Research Centre, Manchester Academic Health Sciences Centre (MAHSC), University of Manchester, Manchester, United KingdomDivision of Psychology & Mental Health, Centre for Mental Health and Safety, Manchester Academic Health Sciences Centre (MAHSC), Faculty of Biology, Medicine and Health, School of Health Sciences, University of Manchester, Manchester, United KingdomDivision of Informatics, Imaging & Data Sciences, Manchester Academic Health Sciences Centre (MAHSC), Faculty of Biology, Medicine and Health, School of Health Sciences, University of Manchester, Manchester, United KingdomNIHR Greater Manchester Patient Safety Translational Research Centre, Manchester Academic Health Sciences Centre (MAHSC), University of Manchester, Manchester, United KingdomCentre for Pharmacoepidemiology and Drug Safety, Manchester Academic Health Sciences Centre (MAHSC), Faculty of Biology, Medicine and Health, School of Health Sciences, University of Manchester, Manchester, United KingdomFarr Institute, Swansea University Medical School, Swansea, United KingdomBolton NHS Foundation Trust, Bolton, United KingdomNeurology and Molecular Neuroscience Research Group, Swansea University Medical School, Swansea University, Swansea, United KingdomNeurology Department, Morriston Hospital, Swansea Bay University Health Board, Swansea, United KingdomFarr Institute, Swansea University Medical School, Swansea, United KingdomNIHR Greater Manchester Patient Safety Translational Research Centre, Manchester Academic Health Sciences Centre (MAHSC), University of Manchester, Manchester, United KingdomCentre for Pharmacoepidemiology and Drug Safety, Manchester Academic Health Sciences Centre (MAHSC), Faculty of Biology, Medicine and Health, School of Health Sciences, University of Manchester, Manchester, United KingdomObjectives: The risk of dying by alcohol-specific causes in people with epilepsy has seldom been reported from population-based studies. We aimed to estimate the relative risk of alcohol-specific mortality in people with epilepsy, and the extent to which problematic alcohol use was previously identified in the patients' medical records.Method: We delineated cohort studies in two population-based datasets, the Clinical Practice Research Datalink (CPRD GOLD) in England (January 01, 2001–December 31, 2014) and the Secure Anonymised Information Linkage (SAIL) Databank in Wales (January 01, 2001–December 31, 2014), linked to hospitalization and mortality records. People with epilepsy were matched to up to 20 persons without epilepsy on gender, age (±2 years) and registered general practice. We identified alcohol-specific death from Office for National Statistics (ONS) records using specified ICD-10 codes. We further identified prescriptions, interventions and hospitalisations related to alcohol use.Results: In the CPRD GOLD, we identified 9,871 individuals in the incident epilepsy cohort and 185,800 in the comparison cohort and, in the SAIL Databank, these numbers were 5,569 and 110,021, respectively. We identified a five-fold increased risk of alcohol-specific mortality in people with epilepsy vs. those without the condition in our pooled estimate across the two datasets (deprivation-adjusted HR 4.85, 95%CI 3.46–6.79).Conclusions: People with epilepsy are at increased risk of dying by an alcohol-specific cause than those without the disorder. It is plausible that serious alcohol misuse could either contribute to the development of epilepsy or it could commence subsequent to epilepsy being diagnosed. Regardless of the direction of the association, it is important that the risk of dying as a consequence of alcohol misuse is accurately quantified in people affected by epilepsy. Systematically-applied, sensitive assessment of alcohol consumption by healthcare professionals, at opportunistic, clinical contacts, with rapid access to quality treatment services, should be mandatory and play a key role in reduction of health harms and mortality.https://www.frontiersin.org/articles/10.3389/fneur.2020.623139/fullepilepsyalcoholalcohol-specificcohortobservational
spellingShingle Hayley C. Gorton
Roger T. Webb
Roger T. Webb
Rosa Parisi
Matthew J. Carr
Matthew J. Carr
Marcos DelPozo-Banos
Kieran J. Moriarty
W. Owen Pickrell
W. Owen Pickrell
Ann John
Darren M. Ashcroft
Darren M. Ashcroft
Alcohol-Specific Mortality in People With Epilepsy: Cohort Studies in Two Independent Population-Based Datasets
Frontiers in Neurology
epilepsy
alcohol
alcohol-specific
cohort
observational
title Alcohol-Specific Mortality in People With Epilepsy: Cohort Studies in Two Independent Population-Based Datasets
title_full Alcohol-Specific Mortality in People With Epilepsy: Cohort Studies in Two Independent Population-Based Datasets
title_fullStr Alcohol-Specific Mortality in People With Epilepsy: Cohort Studies in Two Independent Population-Based Datasets
title_full_unstemmed Alcohol-Specific Mortality in People With Epilepsy: Cohort Studies in Two Independent Population-Based Datasets
title_short Alcohol-Specific Mortality in People With Epilepsy: Cohort Studies in Two Independent Population-Based Datasets
title_sort alcohol specific mortality in people with epilepsy cohort studies in two independent population based datasets
topic epilepsy
alcohol
alcohol-specific
cohort
observational
url https://www.frontiersin.org/articles/10.3389/fneur.2020.623139/full
work_keys_str_mv AT hayleycgorton alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT rogertwebb alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT rogertwebb alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT rosaparisi alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT matthewjcarr alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT matthewjcarr alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT marcosdelpozobanos alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT kieranjmoriarty alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT wowenpickrell alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT wowenpickrell alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT annjohn alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT darrenmashcroft alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets
AT darrenmashcroft alcoholspecificmortalityinpeoplewithepilepsycohortstudiesintwoindependentpopulationbaseddatasets